Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1150 of 3546 entries
View as:

Restless Legs Patient Study On Absorption, Distribution, Metabolism And Excretion Of Ropinirole And The Effect Of Food

Phase: N/A Priority: Normal
NCT ID: NCT00419692 Org: User:
Start: 08/24/06 End: 12/12/06 Due: 12/12/07

A Pilot Study In Adults And Adolescents With Irritant (Non-Allergic) Rhinitis

Phase: N/A Priority: Normal
NCT ID: NCT00730756 Org: User:
Start: 03/31/08 End: 02/28/09 Due: 02/28/10

Study Of Women With Severe Diarrhea-Predominant Irritable Bowel Syndrome Having Failed Conventional Therapy

Phase: N/A Priority: Normal
NCT ID: NCT00067561 Org: User:
Start: 06/30/03 End: 01/31/05 Due: 01/31/06

Cardiovascular (CV) Risk Evaluation In Type 2 Diabetes Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00648284 Org: User:
Start: 03/31/04 End: - Due: -

Long-Term Safety of Treximet (Sumatriptan/Naproxen Sodium) for Migraine in Adolescents

Phase: N/A Priority: Normal
NCT ID: NCT00488514 Org: User:
Start: 07/13/07 End: 08/20/09 Due: 08/20/10

Safety of DTPa-IPV/Hib & DTPa-HBV-IPV/Hib, Followed by DTPa-IPV/Hib Vaccine in Infants Who Received Hepatitis B Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT00325143 Org: User:
Start: 12/01/03 End: 02/01/07 Due: 02/01/08

A Randomized Study Comparing the Efficacy and Safety of Retosiban Versus Atosiban for Women in Spontaneous Preterm Labour

Phase: N/A Priority: Normal
NCT ID: NCT02292771 Org: User:
Start: 03/16/15 End: 08/25/17 Due: 08/25/18

Safety and Immunogenicity Study of a Candidate Tuberculosis Vaccine in Human Immunodeficiency Virus (HIV)-Positive Adults

Phase: N/A Priority: Normal
NCT ID: NCT01262976 Org: User:
Start: 01/17/11 End: 06/04/15 Due: 06/04/16

Study of GSK3965193 in Healthy Participants and Participants Living With Chronic Hepatitis B Infection

Phase: N/A Priority: Normal
NCT ID: NCT05330455 Org: User:
Start: 04/14/22 End: 09/23/27 Due: 09/23/28

A Clinical Study to Investigate the Dermal and Ocular Tolerance of a Developmental Cosmetic Facial Serum Formulation in Healthy Females With Sensitive Skin

Phase: N/A Priority: Normal
NCT ID: NCT03640832 Org: User:
Start: 10/15/18 End: 11/13/18 Due: 11/13/19

A Study to Assess the Safety and Immune Response of a Vaccine Against Influenza in Healthy Younger and Older Adults

Phase: N/A Priority: Normal
NCT ID: NCT05823974 Org: User:
Start: 04/27/23 End: 07/02/24 Due: 07/02/25

SPECT Study With SB-773812 In Schizophrenic Patients

Phase: N/A Priority: Normal
NCT ID: NCT00269035 Org: User:
Start: 06/21/05 End: 05/26/07 Due: 05/26/08

Relative Bioavailability Study of Candesartan Cilexetil Under Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT02254447 Org: User:
Start: 12/02/14 End: 01/08/15 Due: 01/08/16

No Resistance After Long Term Treatment SERETIDE

Phase: N/A Priority: Normal
NCT ID: NCT00456313 Org: User:
Start: 12/31/07 End: 12/31/07 Due: 12/31/08

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Clinical Activity of GSK5733584 for Injection in Participants With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT06431594 Org: User:
Start: 07/02/24 End: 09/20/27 Due: 09/20/28

Study of Belantamab Mafodotin Plus Standard of Care (SoC) in Newly Diagnosed Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT04091126 Org: User:
Start: 12/18/19 End: 12/31/26 Due: 12/31/27

A Study of GSK4527363 in Healthy Participants, Systemic Lupus Erythematosus (SLE) Participants and Healthy Chinese and Japanese Participants

Phase: N/A Priority: Normal
NCT ID: NCT06576271 Org: User:
Start: 09/02/24 End: 06/01/27 Due: 06/01/28

Study to Evaluate the Efficacy of GlaxoSmithKline (GSK) Biologicals' Candidate Tuberculosis (TB) Vaccine in Adults

Phase: N/A Priority: Normal
NCT ID: NCT01755598 Org: User:
Start: 08/19/14 End: 11/16/18 Due: 11/16/19

A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Administering Multiple Oral Doses of GSK1292263 Alone and With Atorvastatin

Phase: N/A Priority: Normal
NCT ID: NCT01218204 Org: User:
Start: 09/14/10 End: 06/29/11 Due: 06/29/12

Clinical Utility Of Genetic Screening For HLA-B*5701, On Susceptibility To Abacavir Hypersensitivity

Phase: N/A Priority: Normal
NCT ID: NCT00340080 Org: User:
Start: 04/30/06 End: - Due: -

Oral HYCAMTIN Plus Whole Brain Radiation Therapy In Treatment Of Brain Metastases Resulting From Non-Small Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00390806 Org: User:
Start: 12/31/06 End: 09/30/13 Due: 09/30/14

Pharmacovigilance Study to Evaluate Safety of SERETIDE in Participants With Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT00662805 Org: User:
Start: 06/30/04 End: 09/30/08 Due: 09/30/09

Pediatric Epilepsy Study in Subjects 1-24 Months

Phase: N/A Priority: Normal
NCT ID: NCT00044278 Org: User:
Start: 09/30/00 End: 06/30/06 Due: 06/30/07

Experimental Medicine Study to Validate Pharmacodynamic Pain Assessments in Healthy Volunteers With an Opioid Analgesic (Remifentanil)

Phase: N/A Priority: Normal
NCT ID: NCT02602002 Org: User:
Start: 04/30/08 End: 06/30/08 Due: 06/30/09

Single Dose Escalation Study FTIM in Order to Assess Safety and Tolerability of GSK610677

Phase: N/A Priority: Normal
NCT ID: NCT00694902 Org: User:
Start: 05/26/08 End: 09/23/08 Due: 09/23/09